12:00 AM
Feb 14, 2000
 |  BC Week In Review  |  Clinical News  |  Clinical Status

Intranasal calcitonin: Began Phase II/III testing

Unigene Inc. (UGNE), Fairfield, N.J.
Product: Intranasal calcitonin
Business: Musculoskeletal
Therapeutic category:...

Read the full 40 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >